Literature DB >> 33502811

Function-Oriented and Modular (+/-)-cis-Pseudoguaianolide Synthesis: Discovery of New Nrf2 Activators and NF-κB Inhibitors.

Fabien Emmetiere1, Ranjala Ratnayake2, Henry A M Schares3, Katherine F M Jones4, Emily Bevan-Smith1, Hendrik Luesch2, Daniel A Harki3,4, Alexander J Grenning1.   

Abstract

Described herein is a function-oriented synthesis route and biological evaluation of pseudoguaianolide analogues. The 10-step synthetic route developed retains the topological complexity of the natural product, installs functional handles for late-stage diversification, and forges the key bioactive Michael acceptors early in the synthesis. The analogues were found to be low-micromolar Nrf2 activators and micromolar NF-κB inhibitors and dependent on the local environment of the Michael acceptor moieties.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  NF-κB inhibitors; Nrf2 activators; enyne metathesis; modular synthesis; pseudoguaianolides

Mesh:

Substances:

Year:  2021        PMID: 33502811      PMCID: PMC8195264          DOI: 10.1002/chem.202100038

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  61 in total

1.  Targeting NF-κB p65 with a Helenalin Inspired Bis-electrophile.

Authors:  John C Widen; Aaron M Kempema; Peter W Villalta; Daniel A Harki
Journal:  ACS Chem Biol       Date:  2016-11-28       Impact factor: 5.100

2.  Expanding the Armory: Predicting and Tuning Covalent Warhead Reactivity.

Authors:  Richard Lonsdale; Jonathan Burgess; Nicola Colclough; Nichola L Davies; Eva M Lenz; Alexandra L Orton; Richard A Ward
Journal:  J Chem Inf Model       Date:  2017-11-21       Impact factor: 4.956

Review 3.  Perspectives on sesquiterpene lactones in inflammation and cancer.

Authors:  Irmgard Merfort
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

4.  The influence of glutathione and cysteine levels on the cytotoxicity of helenanolide type sesquiterpene lactones against KB cells.

Authors:  J Heilmann; M R Wasescha; T J Schmidt
Journal:  Bioorg Med Chem       Date:  2001-08       Impact factor: 3.641

5.  Assembly of Terpenoid Cores by a Simple, Tunable Strategy.

Authors:  Ouidad Lahtigui; Fabien Emmetiere; Wei Zhang; Liban Jirmo; Samira Toledo-Roy; John C Hershberger; Jocelyn M Macho; Alexander J Grenning
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-17       Impact factor: 15.336

6.  Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300.

Authors:  Anke Jakobs; Simone Steinmann; Sarah Marie Henrich; Thomas J Schmidt; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2016-11-01       Impact factor: 5.157

7.  An Enyne Cope Rearrangement Enables Polycycloalkane Synthesis from Readily Available Starting Materials.

Authors:  Sarah K Scott; Alexander J Grenning
Journal:  Angew Chem Int Ed Engl       Date:  2017-06-07       Impact factor: 15.336

8.  Total synthesis of five thapsigargins: guaianolide natural products exhibiting sub-nanomolar SERCA inhibition.

Authors:  Stephen P Andrews; Matthew Ball; Frank Wierschem; Ed Cleator; Steven Oliver; Klemens Högenauer; Oliver Simic; Alessandra Antonello; Udo Hünger; Martin D Smith; Steven V Ley
Journal:  Chemistry       Date:  2007       Impact factor: 5.236

9.  Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation.

Authors:  Yan Li; Yongmei Zeng; Quanfang Huang; Shujuan Wen; Yuanyuan Wei; Ya Chen; Xiaolin Zhang; Facheng Bai; Zhongpeng Lu; Jinbin Wei; Xing Lin
Journal:  Biomed Pharmacother       Date:  2019-09-11       Impact factor: 6.529

Review 10.  Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.

Authors:  Yan-Yang Wang; Yin-Xue Yang; Hong Zhe; Zhi-Xu He; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-10-23       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.